Page last updated: 2024-09-05

cilengitide and Peripheral Nervous System Diseases

cilengitide has been researched along with Peripheral Nervous System Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eadens, M; Erlichman, C; Goetz, MP; Haddad, T; Lupu, R; Molina, J; Qin, R; Satele, D1

Trials

1 trial(s) available for cilengitide and Peripheral Nervous System Diseases

ArticleYear
A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors.
    Cancer chemotherapy and pharmacology, 2017, Volume: 79, Issue:6

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Humans; Integrin alphaVbeta3; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Receptors, Vitronectin; Snake Venoms; Treatment Outcome

2017